Medication & Drug Safety: Great Expectations or Bleak House?
How are drugs studied and approved by the FDA? What does it mean when the FDA says a drug is safe and effective? Join us on Wednesday, January 7, 2015, as Dr. Barton Cobert sheds light on the world of pharmacovigilance, delving into drug regulation, side effects and the realities of taking medications.
Dr. Cobert is a fellow of the American College of Physicians, the American College of Gastroenterology and the Faculty of Pharmaceutical Physicians. He is licensed in 3 states and on the staff at the NYU School of Medicine and UMDNJ. He has worked at Ives Laboratories (now Wyeth), Hoechst-Roussel Pharmaceuticals (now Sanofi-Aventis), Schering-Plough (now Merck), Novartis Consumer Health, Forest Laboratories and Becton Dickinson. He was head of global drug safety at Schering Plough from 1993 until his retirement in 2004. He also headed the global drug safety group at Novartis Consumer Health and has a decade of experience in clinical research. He has written five textbooks (two with Prof. Pierre Biron and one with Dr. Mike Klepper) on Drug Safety including Cobert's Manual of Drug Safety and Pharmacovigilance 2nd edition published by Jones & Bartlett in 2011.